This content is machine translated PMR and LVV: Current EULAR Recommendations Polymyalgia rheumatica, giant cell arteritis, and Takayasu arteritis Giant cell arteritis and Takayasu arteritis are inflammatory conditions affecting the aorta and/or its branch vessels, also known collectively as “large vessel vasculitis ” (LVV ). Polymyalgia rheumatica is an...…
View Post 7 min This content is machine translated Non-anginal chest pain: Could it be a heart attack? From Triage to Secondary Prevention—A Recent Update In cases of chest pain caused by coronary insufficiency, acute coronary syndrome (ACS) should be considered. There is an increased risk in men aged ≥55 and women aged ≥65, as...…
View Post 6 min This content is machine translated Malignant oral squamous cell carcinomas (OPSCC/HNSCC) Innovative Treatment Options The latest data from the AREST study, presented at the 2026 ASCO Annual Meeting, demonstrate that adjuvant radiation therapy following curative surgery for early-stage oral squamous cell carcinoma significantly improves...…
View Post 7 min This content is machine translated Acne vulgaris: Topical and Systemic Treatment Options Spotlight on “Hot Topics” The recent reapproval of topical clascoterone in the U.S., the EU, and the U.K. represents a significant expansion of the therapeutic arsenal. Regarding benzoyl peroxide (BPO), the debate over whether...…
View Post 4 min This content is machine translated CKD and High Blood Pressure Keeping an Eye on Bidirectional Interactions Both hypertension and chronic kidney disease (CKD) are asymptomatic for long periods of time but pose serious health risks, underscoring the importance of timely screening in primary care. In this...…
View Post 5 min This content is machine translated Long COVID/Fatigue Clinic An Innovative Approach: Neuroplasticity and Predictive Processing At the University Hospital of Basel (USB), a promising neuroplastic therapeutic approach is being tested as part of the fatigue clinic. Based on the fundamental assumption that while fatigue and...…
View Post 6 min This content is machine translated Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib First-class immunomodulation combined with convenience—the data available so far is convincing Our understanding of the pathophysiology of psoriasis has improved significantly in recent years, and numerous therapeutic targets have been identified. This has recently led to the development of innovative active...…
View Post 6 min This content is machine translated Myasthenia gravis: immunomodulatory therapies for long-term treatment Expanded Possibilities Thanks to Innovative Classes of Active Ingredients Myasthenic syndromes result from a disturbance in neuromuscular transmission. Although there is still no curative treatment for myasthenia gravis, the drug treatment options available today offer tailored therapeutic approaches aimed...…
View Post 7 min This content is machine translated Ischemic stroke: Are smaller or larger brain arteries affected? Recent study findings on intravenous lysis therapy with fibrinolytic agents Intravenous thrombolysis, with or without mechanical thrombectomy, is a key pillar in the treatment of ischemic stroke. There are now two approved treatment options available—alteplase and tenecteplase—and Phase II data...…
View Post 5 min This content is machine translated Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer? Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs In addition to the EULAR (European Alliance of Associations for Rheumatology)/ACR (American College of Rheumatology) classification criteria, there are other validated tools that facilitate the early detection of SLE, such...…
View Post 4 min This content is machine translated Non-small-cell lung cancer (NSCLC) Long-term data from the CROWN study: Efficacy and intracranial control Updated 7-year data from the CROWN study were presented at the 2026 ASCO Annual Meeting. These data confirm stable long-term disease control with lorlatinib and reinforce its role as a...…